Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription Articles published in Dig Dis Sci Retrieve available abstracts of 210 articles: HTML format Text format

Single Articles

June 2018
1. TSIAOUSSIS GI, Papaioannou EC, Kourea EP, Assimakopoulos SF, et al
   Expression of alpha-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function.
   Dig Dis Sci. 2018 Jun 7. pii: 10.1007/s10620-018-5146.
   PubMed     Text format     Abstract available
   
   
   
2. KOK B, Lester ELW, Lee WM, Hanje AJ, et al
   Acute Liver Failure from Tumor Necrosis Factor-alpha Antagonists: Report of Four Cases and Literature Review.
   Dig Dis Sci. 2018;63:1654-1666.
   PubMed     Text format     Abstract available
   
   
   May 2018
3. BAJAJ JS, Ross D
   Concise Commentary: Remaining Outside the Hospital Is a Golden State in Cirrhosis-Lessons from California.
   Dig Dis Sci. 2018 May 30. pii: 10.1007/s10620-018-5134.
   PubMed     Text format    
   
   
   
4. WALLACE MC, Knuiman M, Huang Y, Garas G, et al
   The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment Variable.
   Dig Dis Sci. 2018 May 28. pii: 10.1007/s10620-018-5132.
   PubMed     Text format     Abstract available
   
   
   
5. SHEN J, Liu J, Li C, Wen T, et al
   The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.
   Dig Dis Sci. 2018 May 7. pii: 10.1007/s10620-018-5077.
   PubMed     Text format     Abstract available
   
   
   
6. WANG P, Li Z, Ren S, Li J, et al
   Spleen Regulates Hematopoietic Stem/Progenitor Cell Functions Through Regulation of EGF in Cirrhotic Hypersplenism.
   Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5091.
   PubMed     Text format     Abstract available
   
   
   
7. FACCIORUSSO A, Roy S, Livadas S, Fevrier-Paul A, et al
   Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites.
   Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5092.
   PubMed     Text format     Abstract available
   
   
   
8. ROTH CG, Marzio DH, Guglielmo FF
   Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs.
   Dig Dis Sci. 2018;63:1102-1122.
   PubMed     Text format     Abstract available
   
   
   
9. KAUNITZ JD
   Magnetic Resonance Imaging: The Nuclear Option.
   Dig Dis Sci. 2018;63:1100-1101.
   PubMed     Text format    
   
   
   
10. NIU B, Kim B, Limketkai BN, Sun J, et al
    Mortality from Spontaneous Bacterial Peritonitis Among Hospitalized Patients in the USA.
    Dig Dis Sci. 2018;63:1327-1333.
    PubMed     Text format     Abstract available
    
    
    April 2018
11. ILAN Y
    Future of Treatment for Nonalcoholic Steatohepatitis: Can the Use of Safe, Evidence-Based, Clinically Proven Supplements Provide the Answer to the Unmet Need?
    Dig Dis Sci. 2018 Apr 20. pii: 10.1007/s10620-018-5080.
    PubMed     Text format     Abstract available
    
    
    
12. SAFADI S, Delu AN, Alcorn J, McCarthy D, et al
    Portal Hypertensive Bleeding: A Navel Approach.
    Dig Dis Sci. 2018 Apr 19. pii: 10.1007/s10620-018-5062.
    PubMed     Text format    
    
    
    
13. GADIPARTHI C, Cholankeril G, Yoo ER, Hu M, et al
    Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Dig Dis Sci. 2018 Apr 2. pii: 10.1007/s10620-018-5032.
    PubMed     Text format     Abstract available
    
    
    March 2018
14. PONZETTO A, Vaira D
    Hepatic Encephalopathy and Helicobacter pylori.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5038.
    PubMed     Text format    
    
    
    
15. DANIELSEN KV, Wiese S, Hove J, Bendtsen F, et al
    Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?
    Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-5006.
    PubMed     Text format     Abstract available
    
    
    
16. ZOU WY, El-Serag HB, Sada YH, Temple SL, et al
    Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population.
    Dig Dis Sci. 2018 Mar 5. pii: 10.1007/s10620-018-4989.
    PubMed     Text format     Abstract available
    
    
    
17. GREMIDA A, Paleti S, Perez ET, McCarthy D, et al
    Hemolysis in Alcoholic Liver Disease: Zieve's Syndrome.
    Dig Dis Sci. 2018;63:601-604.
    PubMed     Text format    
    
    
    February 2018
18. VARDI I, Barel O, Sperber M, Schvimer M, et al
    Genetic and Structural Analysis of a SKIV2L Mutation Causing Tricho-hepato-enteric Syndrome.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4983.
    PubMed     Text format     Abstract available
    
    
    
19. KOUNTOURAS J, Polyzos SA, Katsinelos P, Anastasiadis S, et al
    Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.
    Dig Dis Sci. 2018 Feb 21. pii: 10.1007/s10620-018-4911.
    PubMed     Text format    
    
    
    
20. WEI M, Ford J, Li Q, Jeong D, et al
    Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2018 Feb 19. pii: 10.1007/s10620-018-4964.
    PubMed     Text format     Abstract available
    
    
    
21. MAIER MM, Zhou XH, Chapko M, Leipertz SL, et al
    Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Dig Dis Sci. 2018 Feb 16. pii: 10.1007/s10620-018-4956.
    PubMed     Text format     Abstract available
    
    
    
22. KIM JH, Sinn DH, Lee JH, Hyun D, et al
    Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization.
    Dig Dis Sci. 2018 Feb 13. pii: 10.1007/s10620-018-4934.
    PubMed     Text format     Abstract available
    
    
    
23. YU Z, Wang R, Chen F, Wang J, et al
    Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing.
    Dig Dis Sci. 2018 Feb 13. pii: 10.1007/s10620-018-4961.
    PubMed     Text format     Abstract available
    
    
    
24. MINDIKOGLU AL, Opekun AR, Mitch WE, Magder LS, et al
    Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Feb 1. pii: 10.1007/s10620-017-4897.
    PubMed     Text format     Abstract available
    
    
    
25. ESCORSELL A, Garcia-Pagan JC, Bosch J
    Esophageal Stents for Acute Variceal Bleeding: Expanding the Possibilities.
    Dig Dis Sci. 2018;63:275-276.
    PubMed     Text format    
    
    
    
26. MAIWALL R, Jamwal KD, Bhardwaj A, Bhadoria AS, et al
    SX-Ella Stent Danis Effectively Controls Refractory Variceal Bleed in Patients with Acute-on-Chronic Liver Failure.
    Dig Dis Sci. 2018;63:493-501.
    PubMed     Text format     Abstract available
    
    
    January 2018
27. TORRES-MENA JE, Salazar-Villegas KN, Sanchez-Rodriguez R, Lopez-Gabino B, et al
    Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Dig Dis Sci. 2018 Jan 30. pii: 10.1007/s10620-018-4943.
    PubMed     Text format     Abstract available
    
    
    
28. BAFFY G
    Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2018 Jan 22. pii: 10.1007/s10620-017-4903.
    PubMed     Text format     Abstract available
    
    
    
29. NG PKS, Lau CPY, Lam EKY, Li SSK, et al
    Hypermethylation of NF-kappaB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.
    Dig Dis Sci. 2018 Jan 20. pii: 10.1007/s10620-018-4929.
    PubMed     Text format     Abstract available
    
    
    
30. BENBOW JH, Elam AD, Bossi KL, Massengill DL, et al
    Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.
    Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4860.
    PubMed     Text format     Abstract available
    
    
    
31. BURROUGHS TK, Wade JB, Ellwood MS, Fagan A, et al
    Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Dig Dis Sci. 2018 Jan 8. pii: 10.1007/s10620-017-4894.
    PubMed     Text format     Abstract available
    
    
    
32. LI S, He X, Dang L, Xu F, et al
    Efficacy of (125)I Versus Non-(125)I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.
    Dig Dis Sci. 2018 Jan 5. pii: 10.1007/s10620-017-4899.
    PubMed     Text format     Abstract available
    
    
    December 2017
33. CHOE WH, Kim JH, Park JH, Kim HU, et al
    Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis.
    Dig Dis Sci. 2017 Dec 27. pii: 10.1007/s10620-017-4814.
    PubMed     Text format     Abstract available
    
    
    
34. JONES PD, Diaz C, Wang D, Gonzalez-Diaz J, et al
    The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
    Dig Dis Sci. 2017 Dec 23. pii: 10.1007/s10620-017-4869.
    PubMed     Text format     Abstract available
    
    
    
35. ZHANG X, Li C, Wen T, Peng W, et al
    Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern.
    Dig Dis Sci. 2017 Dec 14. pii: 10.1007/s10620-017-4861.
    PubMed     Text format     Abstract available
    
    
    
36. LIN M, Chang Y, Xie F, Shi Y, et al
    ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-beta1 in Hepatic Stellate Cells by Reducing Autophagy.
    Dig Dis Sci. 2017 Dec 2. pii: 10.1007/s10620-017-4816.
    PubMed     Text format     Abstract available
    
    
    
37. SUK KT, Kim MY, Jeong SW, Jang JY, et al
    Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.
    Dig Dis Sci. 2017 Dec 1. pii: 10.1007/s10620-017-4868.
    PubMed     Text format     Abstract available
    
    
    
38. AHMAD J, Odin JA, Hayashi PH, Chalasani N, et al
    Identification and Characterization of Fenofibrate-Induced Liver Injury.
    Dig Dis Sci. 2017;62:3596-3604.
    PubMed     Text format     Abstract available
    
    
    
39. YANG HJ, Chang Y, Park SK, Jung YS, et al
    Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis.
    Dig Dis Sci. 2017;62:3605-3613.
    PubMed     Text format     Abstract available
    
    
    
40. GLASS LM, Waljee AK, McCurdy H, Su GL, et al
    Specialty Care Access Network-Extension of Community Healthcare Outcomes Model Program for Liver Disease Improves Specialty Care Access.
    Dig Dis Sci. 2017;62:3344-3349.
    PubMed     Text format     Abstract available
    
    
    November 2017
41. LIU H, Hu J, Pan H, Luo D, et al
    CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing beta-Catenin Ubiquitination.
    Dig Dis Sci. 2017 Nov 30. pii: 10.1007/s10620-017-4855.
    PubMed     Text format     Abstract available
    
    
    
42. GANDINI R, Merolla S, Chegai F, Abrignani S, et al
    Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension.
    Dig Dis Sci. 2017 Nov 28. pii: 10.1007/s10620-017-4863.
    PubMed     Text format    
    
    
    
43. PRIVITERA G, Spadaro L, Marchisello S, Fede G, et al
    Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
    Dig Dis Sci. 2017 Nov 25. pii: 10.1007/s10620-017-4862.
    PubMed     Text format     Abstract available
    
    
    
44. ZHOU C, Sun Y, Guo S, Chen X, et al
    Wls Expression Correlates with Tumor Differentiation and TNM Stage in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 10. doi: 10.1007/s10620-017-4823.
    PubMed     Text format     Abstract available
    
    
    
45. TITAN AL, Devereaux K, Louie JD, Poultsides GA, et al
    Clinical Trigonometry: Right Hepatic Trisegmentectomy After Radiation Trisegmentectomy for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 8. doi: 10.1007/s10620-017-4797.
    PubMed     Text format    
    
    
    
46. WIJARNPREECHA K, Chesdachai S, Thongprayoon C, Jaruvongvanich V, et al
    Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy.
    Dig Dis Sci. 2017 Nov 8. doi: 10.1007/s10620-017-4834.
    PubMed     Text format     Abstract available
    
    
    
47. HUANG CS, Zhai JM, Zhu XX, Cai JP, et al
    BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 2. doi: 10.1007/s10620-017-4829.
    PubMed     Text format     Abstract available
    
    
    
48. CULLARO G, Kim G, Pereira MR, Brown RS Jr, et al
    Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2017 Nov 2. doi: 10.1007/s10620-017-4804.
    PubMed     Text format     Abstract available
    
    
    
49. TANEJA S, Borkakoty A, Rathi S, Kumar V, et al
    Assessment of Liver Fibrosis by Transient Elastography Should Be Done After Hemodialysis in End Stage Renal Disease Patients with Liver Disease.
    Dig Dis Sci. 2017;62:3186-3192.
    PubMed     Text format     Abstract available
    
    
    
50. CATRON TD, Smallfield GB, Kang L, Sterling RK, et al
    Endoscopic Cyanoacrylate Injection with Post-injection Audible Doppler Assessment of Gastric Varices: A Single-Institution Experience.
    Dig Dis Sci. 2017;62:3091-3099.
    PubMed     Text format     Abstract available
    
    
    October 2017
51. LU Z, Lin Y, Peng B, Bao Z, et al
    Hydrogen-Rich Saline Ameliorates Hepatic Ischemia-Reperfusion Injury Through Regulation of Endoplasmic Reticulum Stress and Apoptosis.
    Dig Dis Sci. 2017 Oct 30. doi: 10.1007/s10620-017-4811.
    PubMed     Text format     Abstract available
    
    
    
52. WU W, Liu S, Liang Y, Zhou Z, et al
    Stress Hormone Cortisol Enhances Bcl2 Like-12 Expression to Inhibit p53 in Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2017 Oct 17. doi: 10.1007/s10620-017-4798.
    PubMed     Text format     Abstract available
    
    
    
53. KIM JK, Kim HD, Jun MJ, Yun SC, et al
    Correction to: Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Oct 13. doi: 10.1007/s10620-017-4785.
    PubMed     Text format     Abstract available
    
    
    
54. KRUGER AJ, Mumtaz K, Anaizi A, Modi RM, et al
    Cirrhosis Is Associated with Increased Mortality in Patients with Diverticulitis: A Nationwide Cross-Sectional Study.
    Dig Dis Sci. 2017 Oct 6. doi: 10.1007/s10620-017-4782.
    PubMed     Text format     Abstract available
    
    
    
55. OH IS, Sinn DH, Kang TW, Lee MW, et al
    Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Dig Dis Sci. 2017 Oct 5. doi: 10.1007/s10620-017-4775.
    PubMed     Text format     Abstract available
    
    
    
56. REDMAN JS, Natarajan Y, Hou JK, Wang J, et al
    Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing.
    Dig Dis Sci. 2017;62:2713-2718.
    PubMed     Text format     Abstract available
    
    
    
57. KHOURY T, Asombang AW, Berzin TM, Cohen J, et al
    The Clinical Implications of Fatty Pancreas: A Concise Review.
    Dig Dis Sci. 2017;62:2658-2667.
    PubMed     Text format     Abstract available
    
    
    September 2017
58. XING J, Spradling PR, Moorman AC, Holmberg SD, et al
    A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Sep 30. doi: 10.1007/s10620-017-4762.
    PubMed     Text format     Abstract available
    
    
    
59. PARIKH ND, Fu S, Rao H, Yang M, et al
    Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4776.
    PubMed     Text format     Abstract available
    
    
    
60. ROSEN E, Bakshi N, Watters A, Rosen HR, et al
    Hepatic Complications of Anorexia Nervosa.
    Dig Dis Sci. 2017 Sep 20. doi: 10.1007/s10620-017-4766.
    PubMed     Text format     Abstract available
    
    
    
61. ZHANG S, Xiao J, Chai Y, Du YY, et al
    LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Dig Dis Sci. 2017 Sep 18. doi: 10.1007/s10620-017-4759.
    PubMed     Text format     Abstract available
    
    
    
62. HOSSAIN N, Puchakayala B, Kanwar P, Verma S, et al
    Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.
    Dig Dis Sci. 2017 Sep 14. doi: 10.1007/s10620-017-4754.
    PubMed     Text format     Abstract available
    
    
    
63. IKEDA K, Kawamura Y, Kobayashi M, Kominami Y, et al
    Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4739.
    PubMed     Text format     Abstract available
    
    
    
64. OGISO H, Ito H, Kanbe A, Ando T, et al
    The Inhibition of Indoleamine 2,3-Dioxygenase Accelerates Early Liver Regeneration in Mice After Partial Hepatectomy.
    Dig Dis Sci. 2017;62:2386-2396.
    PubMed     Text format     Abstract available
    
    
    
65. LUTZ P, Goeser F, Kaczmarek DJ, Schlabe S, et al
    Relative Ascites Polymorphonuclear Cell Count Indicates Bacterascites and Risk of Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2017;62:2558-2568.
    PubMed     Text format     Abstract available
    
    
    
66. DE LEDINGHEN V, Hiriart JB, Vergniol J, Merrouche W, et al
    Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan((R)): A Comparative Study with the M Probe and Liver Biopsy.
    Dig Dis Sci. 2017;62:2569-2577.
    PubMed     Text format     Abstract available
    
    
    August 2017
67. CHEDID MF
    Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA.
    Dig Dis Sci. 2017 Aug 24. doi: 10.1007/s10620-017-4724.
    PubMed     Text format    
    
    
    
68. CHENG L, Wang H, Han S
    MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Aug 19. doi: 10.1007/s10620-017-4670.
    PubMed     Text format     Abstract available
    
    
    
69. KIM JK, Kim HD, Jun MJ, Yun SC, et al
    Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4708.
    PubMed     Text format     Abstract available
    
    
    
70. XU H, Xiong J, Xu J, Li S, et al
    Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl4-Induced Cirrhotic Rats.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4704.
    PubMed     Text format     Abstract available
    
    
    
71. GREMIDA A, Al-Taee A, Alcorn J, McCarthy D, et al
    Hepatic Dysfunction in Renal Cell Carcinoma: Not What You Think?
    Dig Dis Sci. 2017 Aug 7. doi: 10.1007/s10620-017-4706.
    PubMed     Text format    
    
    
    
72. LEE HW, Kim BK, Kim SU, Park JY, et al
    Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2017;62:2150-2158.
    PubMed     Text format     Abstract available
    
    
    
73. JIMENEZ JV, Carrillo-Perez DL, Rosado-Canto R, Garcia-Juarez I, et al
    Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.
    Dig Dis Sci. 2017;62:1855-1871.
    PubMed     Text format     Abstract available
    
    
    July 2017
74. CHOLANKERIL G, Wong RJ, Hu M, Perumpail RB, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Dig Dis Sci. 2017 Jul 25. doi: 10.1007/s10620-017-4684.
    PubMed     Text format     Abstract available
    
    
    
75. EUN HS, Lee BS, Kwon IS, Yun GY, et al
    Advantages of Laparoscopic Radiofrequency Ablation Over Percutaneous Radiofrequency Ablation in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Jul 25. doi: 10.1007/s10620-017-4688.
    PubMed     Text format     Abstract available
    
    
    June 2017
76. YANG C, Gomez A, Haldipur A, Berquist W, et al
    Growing Concerns: A 3-Year-Old Girl with Multiple Hepatic Masses and Gastrointestinal Bleeding.
    Dig Dis Sci. 2017 Jun 23. doi: 10.1007/s10620-017-4644.
    PubMed     Text format    
    
    
    
77. FITTIPALDI S, Vasuri F, Bonora S, Degiovanni A, et al
    miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
    Dig Dis Sci. 2017 Jun 21. doi: 10.1007/s10620-017-4654.
    PubMed     Text format     Abstract available
    
    
    
78. WU S, Yang C, Xu N, Wang L, et al
    The Protective Effects of Helix B Surface Peptide on Experimental Acute Liver Injury Induced by Carbon Tetrachloride.
    Dig Dis Sci. 2017;62:1537-1549.
    PubMed     Text format     Abstract available
    
    
    
79. SAFADI S, Mohamed AM, Altamimi BA, Strickland RG, et al
    Decompensated Liver Disease in a Patient with Neurocysticercosis.
    Dig Dis Sci. 2017;62:1443-1447.
    PubMed     Text format    
    
    
    May 2017
80. PANTHAM G, Post A, Venkat D, Einstadter D, et al
    A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.
    Dig Dis Sci. 2017 May 30. doi: 10.1007/s10620-017-4630.
    PubMed     Text format     Abstract available
    
    
    
81. WALLACE MC, Huang Y, Preen DB, Garas G, et al
    HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4622.
    PubMed     Text format     Abstract available
    
    
    
82. DE MATTEIS S, Granato AM, Napolitano R, Molinari C, et al
    Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 19. doi: 10.1007/s10620-017-4615.
    PubMed     Text format     Abstract available
    
    
    
83. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
    Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
    PubMed     Text format     Abstract available
    
    
    
84. TAVAKOLI H, Robinson A, Liu B, Bhuket T, et al
    Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 4. doi: 10.1007/s10620-017-4595.
    PubMed     Text format     Abstract available
    
    
    
85. DOYCHEVA I, Watt KD, Rifai G, Abou Mrad R, et al
    Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.
    Dig Dis Sci. 2017;62:1373-1380.
    PubMed     Text format     Abstract available
    
    
    
86. GAIDOS JKJ, Fuchs M
    Increased Prevalence of NAFLD in IBD Patients.
    Dig Dis Sci. 2017;62:1362.
    PubMed     Text format    
    
    
    April 2017
87. HAMARNEH SR, Kim BM, Kaliannan K, Morrison SA, et al
    Intestinal Alkaline Phosphatase Attenuates Alcohol-Induced Hepatosteatosis in Mice.
    Dig Dis Sci. 2017 Apr 19. doi: 10.1007/s10620-017-4576.
    PubMed     Text format     Abstract available
    
    
    
88. YOSHIDA T, Akiba J, Matsui T, Nakamura K, et al
    Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4550.
    PubMed     Text format     Abstract available
    
    
    
89. TESCHKE R, Eickhoff A
    Suspected Liver Injury and the Dilemma of Causality.
    Dig Dis Sci. 2017;62:1095-1098.
    PubMed     Text format     Abstract available
    
    
    March 2017
90. CARR RM, Patel A, Bownik H, Oranu A, et al
    Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4495.
    PubMed     Text format     Abstract available
    
    
    
91. KOHLI DR, Vachhani R, Shah TU, BouHaidar DS, et al
    Diagnostic Accuracy of Laboratory Tests and Diagnostic Imaging in Detecting Biliary Strictures After Liver Transplantation.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4515.
    PubMed     Text format     Abstract available
    
    
    
92. PATIDAR KR, Thacker LR, Wade JB, White MB, et al
    Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis.
    Dig Dis Sci. 2017 Mar 3. doi: 10.1007/s10620-017-4509.
    PubMed     Text format     Abstract available
    
    
    
93. KALAFATELI M, Zisimopoulos K, Vourli G, Rigamonti C, et al
    Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.
    Dig Dis Sci. 2017 Mar 1. doi: 10.1007/s10620-017-4504.
    PubMed     Text format     Abstract available
    
    
    
94. O'LEARY JG, Wong F, Reddy KR, Garcia-Tsao G, et al
    Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience.
    Dig Dis Sci. 2017;62:768-776.
    PubMed     Text format     Abstract available
    
    
    
95. HEIDEMANN L, Law J, Fontana RJ
    A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury.
    Dig Dis Sci. 2017;62:615-625.
    PubMed     Text format     Abstract available
    
    
    February 2017
96. LIN MX, Ye JY, Tian WS, Xu M, et al
    Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case-Control Study.
    Dig Dis Sci. 2017 Feb 15. doi: 10.1007/s10620-016-4312.
    PubMed     Text format     Abstract available
    
    
    
97. CAI CX, Buddha H, Castelino-Prabhu S, Zhang Z, et al
    Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2017 Feb 13. doi: 10.1007/s10620-017-4470.
    PubMed     Text format     Abstract available
    
    
    
98. KIM G, Huh JH, Lee KJ, Kim MY, et al
    Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2017 Feb 7. doi: 10.1007/s10620-017-4471.
    PubMed     Text format     Abstract available
    
    
    
99. BALAKRISHNAN M, El-Serag HB, Kanwal F, Thrift AP, et al
    Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.
    Dig Dis Sci. 2017;62:526-533.
    PubMed     Text format     Abstract available
    
    
    
100. KUO SZ, Haftek M, Lai JC
     Factors Associated with Medication Non-adherence in Patients with End-Stage Liver Disease.
     Dig Dis Sci. 2017;62:543-549.
     PubMed     Text format     Abstract available
     
     
     January 2017
101. HUNG TH, Tseng CW, Tsai CC, Hsieh YH, et al
     Mortality Following Catheter Drainage Versus Thoracentesis in Cirrhotic Patients with Pleural Effusion.
     Dig Dis Sci. 2017 Jan 27. doi: 10.1007/s10620-017-4463.
     PubMed     Text format     Abstract available
     
     
     
102. ZHAO D, Luo Y, Xia Y, Zhang JJ, et al
     MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis.
     Dig Dis Sci. 2017 Jan 12. doi: 10.1007/s10620-016-4411.
     PubMed     Text format     Abstract available
     
     
     
103. RIVEIRO-BARCIELA M, Tabernero D, Calleja JL, Lens S, et al
     Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma.
     Dig Dis Sci. 2017 Jan 11. doi: 10.1007/s10620-017-4448.
     PubMed     Text format     Abstract available
     
     
     
104. YAN X, Shao C, Chen C, Chen J, et al
     Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing.
     Dig Dis Sci. 2017 Jan 5. doi: 10.1007/s10620-016-4408.
     PubMed     Text format     Abstract available
     
     
     
105. KIM SK, Belikoff BG, Guevara CJ, Park SJ, et al
     An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations.
     Dig Dis Sci. 2017 Jan 5. doi: 10.1007/s10620-016-4399.
     PubMed     Text format     Abstract available
     
     
     
106. LEIBOVICI-WEISSMAN Y, Mor E, Leshno M, Shlomai A, et al
     Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation.
     Dig Dis Sci. 2017 Jan 4. doi: 10.1007/s10620-016-4423.
     PubMed     Text format     Abstract available
     
     
     
107. HU X, Feng Y, Sun L, Qu L, et al
     Roles of microRNA-330 and Its Target Gene ING4 in the Development of Aggressive Phenotype in Hepatocellular Carcinoma Cells.
     Dig Dis Sci. 2017 Jan 3. doi: 10.1007/s10620-016-4429.
     PubMed     Text format     Abstract available
     
     
     
108. SRIDHAR A, Cwiak CA, Kaunitz AM, Allen RH, et al
     Contraceptive Considerations for Women with Gastrointestinal Disorders.
     Dig Dis Sci. 2017;62:54-63.
     PubMed     Text format     Abstract available
     
     
     December 2016
109. NARDELLI S, Allampati S, Riggio O, Mullen KD, et al
     Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.
     Dig Dis Sci. 2016 Dec 30. doi: 10.1007/s10620-016-4425.
     PubMed     Text format     Abstract available
     
     
     
110. KIM EJ, Yeon JE, Kwon OS, Lee HN, et al
     Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
     Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4431.
     PubMed     Text format     Abstract available
     
     
     
111. GOOSSENS N, Breguet R, De Vito C, Terraz S, et al
     Peribiliary Gland Dilatation in Cirrhosis: Relationship with Liver Failure and Stem Cell/Proliferation Markers.
     Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4421.
     PubMed     Text format     Abstract available
     
     
     
112. ANDREWS R, Queen T, Alcorn J, McCarthy D, et al
     A Remembrance of Procedures Past: Late Hepatic Artery Thrombosis.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
113. LI C, Wu M, Zong G, Wan C, et al
     Overexpression of Protein Phosphatase 1gamma (PP1gamma) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
114. ISHIOKA M, Miura K, Minami S, Shimura Y, et al
     Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     November 2016
115. KAPLAN DE
     Prediction of Mortality in Chronic Liver Disease Using Non-hepatic Comorbidities: No SI of Relief as Yet.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
116. HWANG GL, Sze DY
     Survival in Cirrhotic Patients with High MELD Scores: The TIPping Point.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
117. DONOVAN RJ, Choi C, Ali A, Heuman DM, et al
     Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
118. WALLING AM, Ahluwalia SC, Wenger NS, Booth M, et al
     Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     October 2016
119. HA TH, Kim BG, Jeong D, Oh S, et al
     Alcoholic Liver Disease Is Associated with an Increased Risk of Gastric Cancer.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
120. TSOU YK, Liu CY, Fu KI, Lin CH, et al
     Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasms Is Feasible and Not Riskier for Patients with Liver Cirrhosis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
121. HEIDEMANN LA, Navarro VJ, Ahmad J, Hayashi PH, et al
     Erratum to: Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
122. QIU X, Wang X, Song Y, Chen L, et al
     Plasma Level of Interleukin-35 as an Independent Prognostic Indicator in Hepatocellular Carcinoma.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     September 2016
123. WONG RJ
     Incorporating Clinical Research into a Career in Gastroenterology and Hepatology.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
124. ALLEGRETTI AS, Ortiz G, Kalim S, Wibecan J, et al
     Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
125. DONG T, Aronsohn A, Gautham Reddy K, Te HS, et al
     Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
126. NATARAJAN Y, White DL, El-Serag HB, Ramsey D, et al
     Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     August 2016
127. HOEFS JC
     Prevention of the Paracentesis-Induced Circulatory Dysfunction (PICD) in Cirrhosis: Is the SPA Treatment Worthwhile?
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
128. SOTIROPOULOS GC, Vernadakis S, Paul A, Hoyer DP, et al
     Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
129. LIU TL, Trogdon J, Weinberger M, Fried B, et al
     Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     July 2016
130. HOU F, Qi X, Guo X
     Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
131. MONTANO-LOZA AJ, Thandassery RB, Czaja AJ
     Targeting Hepatic Fibrosis in Autoimmune Hepatitis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
132. KIM JH, Sinn DH, Kim K, Kang W, et al
     Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
133. HEGADE VS, Khanna A, Walker LJ, Wong LL, et al
     Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
134. CHOUDHARY A, Barakat MT, Higgins LJ, Banerjee S, et al
     Choledochoscopic Identification of a Hepatic/Cystic Artery Pseudoaneurysm in a Patient with Hematemesis After Laparoscopic Cholecystectomy.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
135. KAPLAN DE, Dai F, Skanderson M, Aytaman A, et al
     Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     June 2016
136. KUEI A, Lee EW, Saab S, Busuttil RW, et al
     Inpatient Cost Assessment of Transjugular Intrahepatic Portosystemic Shunt in the USA from 2001 to 2012.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
137. SCLAIR SN, Carrasquillo O, Czul F, Trivella JP, et al
     Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
138. CAMUS M, Khungar V, Jensen DM, Ohning GV, et al
     Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
139. THOMAS E, Schiff ER
     Early Detection of Steatohepatitis: Less Teeth NASHing and More Research?
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     May 2016
140. LIU J, Ni W, Qu L, Cui X, et al
     Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
141. FAN X, Liu K, Che Y, Wang S, et al
     Good Clinical Outcomes in Budd-Chiari Syndrome with Hepatic Vein Occlusion.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
142. ASCHA M, Hanouneh M, S Ascha M, Zein NN, et al
     Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease >/=15.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
143. HEIDEMANN LA, Navarro VJ, Ahmad J, Hayashi PH, et al
     Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
144. FUCHS M, Schnabl B
     Editors' Introduction to the NAFLD and NASH Special Issue.
     Dig Dis Sci. 2016;61:1211-3.
     PubMed     Text format    
     
     
     
145. HANNAH WN JR, Harrison SA
     Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2016;61:1365-74.
     PubMed     Text format     Abstract available
     
     
     
146. AFRICA JA, Newton KP, Schwimmer JB
     Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children.
     Dig Dis Sci. 2016;61:1375-86.
     PubMed     Text format     Abstract available
     
     
     
147. SHERIF ZA, Saeed A, Ghavimi S, Nouraie SM, et al
     Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations.
     Dig Dis Sci. 2016;61:1214-25.
     PubMed     Text format     Abstract available
     
     
     
148. KASWALA DH, Lai M, Afdhal NH
     Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
     Dig Dis Sci. 2016;61:1356-64.
     PubMed     Text format     Abstract available
     
     
     
149. RATZIU V
     Novel Pharmacotherapy Options for NASH.
     Dig Dis Sci. 2016;61:1398-405.
     PubMed     Text format     Abstract available
     
     
     
150. GOH GB, McCullough AJ
     Natural History of Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2016;61:1226-33.
     PubMed     Text format     Abstract available
     
     
     
151. ABDOU RM, Zhu L, Baker RD, Baker SS, et al
     Gut Microbiota of Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2016;61:1268-81.
     PubMed     Text format     Abstract available
     
     
     
152. BEDOSSA P
     Histological Assessment of NAFLD.
     Dig Dis Sci. 2016;61:1348-55.
     PubMed     Text format     Abstract available
     
     
     
153. KINNER S, Reeder SB, Yokoo T
     Quantitative Imaging Biomarkers of NAFLD.
     Dig Dis Sci. 2016;61:1337-47.
     PubMed     Text format     Abstract available
     
     
     
154. ARRESE M, Cabrera D, Kalergis AM, Feldstein AE, et al
     Innate Immunity and Inflammation in NAFLD/NASH.
     Dig Dis Sci. 2016;61:1294-303.
     PubMed     Text format     Abstract available
     
     
     
155. MANTOVANI A, Ballestri S, Lonardo A, Targher G, et al
     Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2016;61:1246-67.
     PubMed     Text format     Abstract available
     
     
     
156. SZABO G, Csak T
     Role of MicroRNAs in NAFLD/NASH.
     Dig Dis Sci. 2016;61:1314-24.
     PubMed     Text format     Abstract available
     
     
     
157. CZAJA MJ
     Function of Autophagy in Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2016;61:1304-13.
     PubMed     Text format     Abstract available
     
     
     April 2016
158. LIN XJ, Lao XM, Shi M, Li SP, et al
     Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
159. ZONG G, Xu Z, Zhang S, Shen Y, et al
     CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
160. MENDEL I, Yacov N, Shoham A, Ishai E, et al
     Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
161. CHO Y, Cho EJ, Lee JH, Yu SJ, et al
     Hypoxia Enhances Tumor-Stroma Crosstalk that Drives the Progression of Hepatocellular Carcinoma.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
162. COZEN ML, Ryan JC, Shen H, Cheung R, et al
     Improved Survival Among all Interferon-alpha-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
163. ZHANG RN, Zheng RD, Mi YQ, Zhou D, et al
     APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
164. BRUNS T, Reuken PA, Stengel S, Gerber L, et al
     NOD2 Risk Variants and Pathological Bacterial Translocation in Decompensated Cirrhosis.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
165. TAN HK, James PD, Wong F
     Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
166. PECTASIDES E, Miksad R, Pyatibrat S, Srivastava A, et al
     Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
167. JUNG YS, Yun KE, Chang Y, Ryu S, et al
     Risk Factors Such as Male Sex, Smoking, Metabolic Syndrome, Obesity, and Fatty Liver Do Not Justify Screening Colonoscopies Before Age 45.
     Dig Dis Sci. 2016;61:1021-7.
     PubMed     Text format     Abstract available
     
     
     March 2016
168. VUPPALANCHI R, Chalasani N
     Screening Strategies for Nonalcoholic Steatohepatitis in High-Risk Individuals: Trimming Away the Fat.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
169. SARGENTI K, Johansson A, Bertilsson S, Mattsby-Baltzer I, et al
     Dysfunction of Circulating Polymorphonuclear Leukocytes and Monocytes in Ambulatory Cirrhotics Predicts Patient Outcome.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
170. ZHOU H, Li Y, Song X, Zhao Y, et al
     CHST11/13 Regulate the Metastasis and Chemosensitivity of Human Hepatocellular Carcinoma Cells Via Mitogen-Activated Protein Kinase Pathway.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
171. NAGPAL SJ, Kabbany MN, Mohamad B, Lopez R, et al
     Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
172. JARUVONGVANICH V, Sanguankeo A, Upala S
     Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
173. MOHANTY A, Fortune BE
     Why Pursue a Fourth Year in Advanced/Transplant Hepatology?
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
174. ZHU Z, Chen W, Yin X, Lai J, et al
     WAVE3 Induces EMT and Promotes Migration and Invasion in Intrahepatic Cholangiocarcinoma.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
175. TANG S, Zeng W, Qin J, He Q, et al
     Gastric Variceal Bleeding Caused by an Arterioportal Fistula Formation After TIPS and Related Complications.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
176. COREY KE, Rinella ME
     Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
177. COREY KE, Kartoun U, Zheng H, Shaw SY, et al
     Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record.
     Dig Dis Sci. 2016;61:913-9.
     PubMed     Text format     Abstract available
     
     
     
178. CHO SB, Choi YH, So YH, Ahn DW, et al
     Balloon-Occluded Retrograde Transvenous Obliteration of Jejunal Varices: A Case Report, Therapeutic Approach.
     Dig Dis Sci. 2016;61:948-51.
     PubMed     Text format    
     
     
     
179. KAWANISHI K, Kato J, Toda N, Yamagami M, et al
     Risk Factors for Aspiration Pneumonia After Endoscopic Hemostasis.
     Dig Dis Sci. 2016;61:835-40.
     PubMed     Text format     Abstract available
     
     
     
180. PIMENTEL CF, Jiang ZG, Otsubo T, Feldbrugge L, et al
     Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH.
     Dig Dis Sci. 2016;61:905-12.
     PubMed     Text format     Abstract available
     
     
     February 2016
181. DE CARVALHO BT, Coutinho Domingues AL, de Almeida Lopes EP, Brandao SC, et al
     Increased Hepatic Arterial Blood Flow Measured by Hepatic Perfusion Index in Hepatosplenic Schistosomiasis: New Concepts for an Old Disease.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
182. REEVES HL, Zaki MY, Day CP
     Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
183. CARR BI, Guerra V
     Erratum to: Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
184. CHEN L, Guo YZ, Li AD, Ma JJ, et al
     Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
185. SOFTIC S, Cohen DE, Kahn CR
     Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
186. HAAS K, Longacre T, Castillo RO
     Adenovirus Hepatic Abscess: A Novel Source of Fever of Unknown Origin in a Pediatric Liver Transplant Recipient.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     January 2016
187. COREY KE, Klebanoff MJ, Tramontano AC, Chung RT, et al
     Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
188. PATEL YA, Berg CL, Moylan CA
     Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
189. YARZE N, Yarze JC
     Radiographic and Histologic Findings of a Rare Liver Tumor-Hepatic Epithelioid Hemangioendothelioma.
     Dig Dis Sci. 2016.
     PubMed     Text format    
     
     
     
190. LANDIS CS, Ghabril M, Rustgi V, Di Bisceglie AM, et al
     Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
191. KAJIHARA J, Tomimaru Y, Eguchi H, Yamada D, et al
     The Clinical Impact of Transcatheter Arterial Chemoembolization (TACE)-Induced c-Met Upregulation on TACE Refractoriness in Hepatocellular Carcinoma.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
192. INTAGLIATA NM, Henry ZH, Maitland H, Shah NL, et al
     Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
193. BORHOFEN SM, Gerner C, Lehmann J, Fimmers R, et al
     The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis.
     Dig Dis Sci. 2016.
     PubMed     Text format     Abstract available
     
     
     
194. HA J, Hendrix M, Guyer AG
     Microwave Ablation for the Treatment of Hypersplenism: Short Waves, Low Cost, Big Results.
     Dig Dis Sci. 2016;61:6-7.
     PubMed     Text format    
     
     
     
195. PETRONE MC, Arcidiacono PG
     EUS-Guided Drainage of Liver Abscesses: Ultra Uncertain or Sound Practice?
     Dig Dis Sci. 2016;61:8-10.
     PubMed     Text format    
     
     
     
196. LEE T, Yun KE, Chang Y, Ryu S, et al
     Risk of Colorectal Neoplasia According to Fatty Liver Severity and Presence of Gall Bladder Polyps.
     Dig Dis Sci. 2016;61:317-24.
     PubMed     Text format     Abstract available
     
     
     
197. OGURA T, Masuda D, Saori O, Wataru T, et al
     Clinical Outcome of Endoscopic Ultrasound-Guided Liver Abscess Drainage Using Self-Expandable Covered Metallic Stent (with Video).
     Dig Dis Sci. 2016;61:303-8.
     PubMed     Text format     Abstract available
     
     
     December 2015
198. DYAL HK, Aguilar M, Bartos G, Holt EW, et al
     Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review.
     Dig Dis Sci. 2015.
     PubMed     Text format     Abstract available
     
     
     
199. WANG JH, Chen TY, Ou HY, Wang CC, et al
     Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study.
     Dig Dis Sci. 2015.
     PubMed     Text format     Abstract available
     
     
     
200. AN J, Zheng L, Xie S, Yin F, et al
     Regulatory Effects and Mechanism of Adenovirus-Mediated PTEN Gene on Hepatic Stellate Cells.
     Dig Dis Sci. 2015.
     PubMed     Text format     Abstract available
     
     
     
201. DOU CY, Fan YC, Cao CJ, Yang Y, et al
     Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
     Dig Dis Sci. 2015.
     PubMed     Text format     Abstract available
     
     
     
202. IBRAHIM SH, Hirsova P, Malhi H, Gores GJ, et al
     Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame.
     Dig Dis Sci. 2015.
     PubMed     Text format     Abstract available
     
     
     
203. XIE M, Zhu J, He X, Yang Z, et al
     Liver Metastasis from Colorectal Cancer in the Elderly: Is Surgery Justified?
     Dig Dis Sci. 2015;60:3525-35.
     PubMed     Text format     Abstract available
     
     
     November 2015
204. BLACK SM, Woodley FW, Tumin D, Mumtaz K, et al
     Cystic Fibrosis Associated with Worse Survival After Liver Transplantation.
     Dig Dis Sci. 2015.
     PubMed     Text format     Abstract available
     
     
     
205. CARR BI, Guerra V
     Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
     Dig Dis Sci. 2015.
     PubMed     Text format     Abstract available
     
     
     
206. PARK CH, Han DS, Jeong JY, Eun CS, et al
     Outcomes of Propofol Sedation During Emergency Endoscopy Performed for Upper Gastrointestinal Bleeding.
     Dig Dis Sci. 2015.
     PubMed     Text format     Abstract available
     
     
     
207. ZHU JZ, Dai YN, Wang YM, Zhou QY, et al
     Prevalence of Nonalcoholic Fatty Liver Disease and Economy.
     Dig Dis Sci. 2015;60:3194-202.
     PubMed     Text format     Abstract available
     
     
     October 2015
208. GRAT M, Wronka KM, Patkowski W, Stypulkowski J, et al
     Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status.
     Dig Dis Sci. 2015.
     PubMed     Text format     Abstract available
     
     
     
209. CHUNG H, Chon YE, Kim SU, Lee SK, et al
     Noninvasive Prediction of Erosive Esophagitis Using a Controlled Attenuation Parameter (CAP)-Based Risk Estimation Model.
     Dig Dis Sci. 2015.
     PubMed     Text format     Abstract available
     
     
     September 2015
210. URRUNAGA NH, Magder LS, Weir MR, Rockey DC, et al
     Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List.
     Dig Dis Sci. 2015.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: